Cargando…
Urinary pyridinoline cross-links as biomarkers of osteogenesis imperfecta
Osteogenesis imperfecta (OI) is a group of genetic heterogeneous connective tissue disorders characterized by increased bone fragility and susceptibility to fractures. Laboratory diagnosis relies on time-consuming and cost-intensive biochemical and molecular genetics analyses. Therefore, it is desir...
Autores principales: | Lindert, Uschi, Kraenzlin, Marius, Campos-Xavier, Ana Belinda, Baumgartner, Matthias R., Bonafé, Luisa, Giunta, Cecilia, Rohrbach, Marianne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549897/ https://www.ncbi.nlm.nih.gov/pubmed/26306627 http://dx.doi.org/10.1186/s13023-015-0315-9 |
Ejemplares similares
-
Omics Profiling of S2P Mutant Fibroblasts as a Mean to Unravel the Pathomechanism and Molecular Signatures of X-Linked MBTPS2 Osteogenesis Imperfecta
por: Lim, Pei Jin, et al.
Publicado: (2021) -
MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta
por: Lindert, Uschi, et al.
Publicado: (2016) -
Insight into the Pathology of a COL1A1 Signal Peptide Heterozygous Mutation Leading to Severe Osteogenesis Imperfecta
por: Lindert, U., et al.
Publicado: (2017) -
Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis.
por: Sano, M., et al.
Publicado: (1994) -
Perturbations in fatty acid metabolism and collagen production infer pathogenicity of a novel MBTPS2 variant in Osteogenesis imperfecta
por: Lim, Pei Jin, et al.
Publicado: (2023)